Journals / European Journal of Breast Health / 2022 / Cilt: 18 - Sayı: 1

The Impact of the COVID-19 Pandemic on Breast Cancer Patients

Pages
85–90
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The rate of de novo stage IV breast cancer was also significantly increased.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The coronavirus disease-2019 (COVID-19) pandemic causes delays in the diagnosis and treatment of cancer patients due to fear of contagion and lockdown.
📊
Key Findings & Data:This study aims to investigate the effects of the COVID-19 pandemic on breast cancer patients treated in our breast center.
💡
Conclusion & Impact:The rate of de novo stage IV breast cancer was also significantly increased.
🔬Design:Research Article
📍Scope:2019 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: The coronavirus disease-2019 (COVID-19) pandemic causes delays in the diagnosis and treatment of cancer patients due to fear of contagion and lockdown. This study aims to investigate the effects of the COVID-19 pandemic on breast cancer patients treated in our breast center. Materials and Methods: Patients who applied to our clinic with the diagnosis of invasive breast cancer in March 2020 and March 2021 (Study Group) when the COVID-19 pandemic was observed, and in March 2019 and March 2020 before the COVID-19 pandemic (Control Group) were compared in terms of demographic, clinical and pathological characteristics. Statistical analyses were performed using the SPSS software version 21. Results: There were 176 (46%) patients in the study and 206 (54%) patients in the control group. Almost a 15% reduction was detected in patients admitted during the COVID-19 pandemic. The rate of pre-menopausal patients and patient-related delay time (PRDT) were significantly higher in SG (57.7% vs. %45, p=0.013, 2.58 vs. 1.82-month, p=0.001, respectively). There was a larger tumor size and more metastatic lymph nodes after NAC in the SG, but the differences were not significant. There was no difference regarding breast cancer stages and molecular subtypes between the two groups, but there was significantly more de novo stage IV breast cancer in the SG (p=0.009). The incidence of neo-adjuvant chemotherapy and type of surgical therapy was similar between the two groups. Conclusion: COVID-19 pandemic caused a decrease in the number of patients who applied to our clinic and increased patient-related delay time due to fear of transmission and lockdown. The rate of de novo stage IV breast cancer was also significantly increased.

🔖

Cite This Article

ÖZMEN, V., İLGÜN, A. S. (2022). The Impact of the COVID-19 Pandemic on Breast Cancer Patients. European Journal of Breast Health, Cilt: 18 - Sayı: 1, 85–90. https://ajindex.com/articles/510643

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. World Health Organization. Archived: WHO Timeline - COVID-19. Available at: https://www.who.int/news/item/27-04-2020-who-timeline- --covid-19 [Crossref ] 2. Sağlık Bakanlığı. Bakan Koca, Türkiye’nin Kovid-19’la 1 Yıllık Mücadele Sürecini Değerlendirdi. Available at: https://www.saglik.gov. tr/TR,80604/bakan-koca-turkiyenin-kovid-19la-1-yillik-mucadelesurecini- degerlendirdi.html [Crossref ] 3. COVIDSurg Collaborative. Global guidance for surgical care during the COVID-19 pandemic. Br J Surg 2020
  2. 1 07: 1097-1103. (PMID: 32293715) [Crossref ] 4. COVIDSurg Collaborative. Elective surgery cancellations due to the COVID-19 pandemic: global predictive modelling to inform surgical recovery plans. Br J Surg. 2020
  3. (PMID: 32395848) [Crossref ] 5. Ponkilainen V, Kuitunen I, Hevonkorpi TP, Paloneva J, Reito A, Launonen AP, Mattila VM. The effect of nationwide lockdown and societal restrictions due to COVID-19 on emergency and urgent surgeries. Br J Surg 2020
  4. e405-e406. (PMID: 32770538) [Crossref ] 6. Ozmen V, Boylu S, Ok E, Canturk NZ, Celik V, Kapkac M, et al. Factors affecting breast cancer treatment delay in Turkey: a study from Turkish Federation of Breast Diseases Societies. Eur J Public Health 2015
  5. 14 (PMID: 25096257) [Crossref ] 7. Filipe MD, van Deukeren D, Kip M, Doeksen A, Pronk A, Verheijen PM, Heikens JT, et al. Effect of the COVID-19 Pandemic on Surgical Breast Cancer Care in the Netherlands: A Multicenter Retrospective Cohort Study. Clin Breast Cancer 2020
  6. (PMID: 32888855) [Crossref ] 8. Dauti Işıklar A, Deniz C, Soyder A, Güldoğan N, Yılmaz E, Başaran G. How Do Breast Cancer Patients Present Following COVID-19 Early Peak in a Breast Cancer Center in Turkey? Eur J Breast Health 2021
  7. (PMID: 34263153) [Crossref ] 9. Vidya R, Rubio IT, Paulinelli RR, Rancati A, Kolacinska-Voytkuv A, Salgarello M, et al. Should breast reconstruction and breast oncoplastic procedures be performed during the coronavirus pandemic? Ecancermedicalscience 2020
  8. (PMID: 32565894) [Crossref ] 10. Smith EC, Ziogas A, Anton-Culver H. Delay in surgical treatment and survival after breast cancer diagnosis in young women by race/ethnicity. JAMA Surg 2013
  9. (PMID: 23615681) [Crossref ] 11. Hansen RP, Vedsted P, Sokolowski I, Søndergaard J, Olesen F. General practitioner characteristics and delay in cancer diagnosis. a populationbased cohort study. BMC Fam Pract 2011
  10. (PMID: 21943310) [Crossref ] 1